Abstract

Based on our 7 and one-half-year experience with liver transplantation at the University of Nebraska Medical Center: 1. Success and growth of the program has been, in part, the result of close interaction and support of the various specialists involved. 2. We have demonstrated that outstanding patient and graft survival rates can be obtained with cyclosporine/prednisone immunosuppression. 3. Few, if any, technical contraindications exist to liver transplantation. 4. Surgical advances have allowed allografts to be salvaged which would otherwise require replacement. 5. Routine donor-liver biopsy prior to implantation has reduced the rate of primary nonfunction. 6. New strategies to improve survival for patients with hepatitis-B-related liver disease and hepatic malignancies undergoing liver transplantation need to be developed. 7. The management of patients with fulminant hepatic failure is evolving and now includes innovative approaches such as the use of ECLS and auxiliary transplants.

Original languageEnglish (US)
Pages (from-to)167-177
Number of pages11
JournalClinical transplants
StatePublished - Jan 1 1992

Fingerprint

Liver Transplantation
Acute Liver Failure
Liver
Graft Survival
Prednisone
Hepatitis B
Immunosuppression
Cyclosporine
Allografts
Liver Diseases
Survival Rate
Tissue Donors
Transplants
Biopsy
Survival
Growth
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Liver transplantation at the University of Nebraska Medical Center from 1985 to 1992. / Langnas, Alan Norman; Donovan, J. P.; Sorrell, Michael Floyd; Zetterman, Rowen K; Antonson, D. L.; Stratta, R. J.; Fox, I. J.; Heffron, T. G.; Markin, Rodney Smith; Pillen, T. J.

In: Clinical transplants, 01.01.1992, p. 167-177.

Research output: Contribution to journalArticle

@article{10062a8f1a864de5bbe843036b3988b5,
title = "Liver transplantation at the University of Nebraska Medical Center from 1985 to 1992.",
abstract = "Based on our 7 and one-half-year experience with liver transplantation at the University of Nebraska Medical Center: 1. Success and growth of the program has been, in part, the result of close interaction and support of the various specialists involved. 2. We have demonstrated that outstanding patient and graft survival rates can be obtained with cyclosporine/prednisone immunosuppression. 3. Few, if any, technical contraindications exist to liver transplantation. 4. Surgical advances have allowed allografts to be salvaged which would otherwise require replacement. 5. Routine donor-liver biopsy prior to implantation has reduced the rate of primary nonfunction. 6. New strategies to improve survival for patients with hepatitis-B-related liver disease and hepatic malignancies undergoing liver transplantation need to be developed. 7. The management of patients with fulminant hepatic failure is evolving and now includes innovative approaches such as the use of ECLS and auxiliary transplants.",
author = "Langnas, {Alan Norman} and Donovan, {J. P.} and Sorrell, {Michael Floyd} and Zetterman, {Rowen K} and Antonson, {D. L.} and Stratta, {R. J.} and Fox, {I. J.} and Heffron, {T. G.} and Markin, {Rodney Smith} and Pillen, {T. J.}",
year = "1992",
month = "1",
day = "1",
language = "English (US)",
pages = "167--177",
journal = "Clinical transplants",
issn = "0890-9016",
publisher = "UCLA Immunogenetics Center",

}

TY - JOUR

T1 - Liver transplantation at the University of Nebraska Medical Center from 1985 to 1992.

AU - Langnas, Alan Norman

AU - Donovan, J. P.

AU - Sorrell, Michael Floyd

AU - Zetterman, Rowen K

AU - Antonson, D. L.

AU - Stratta, R. J.

AU - Fox, I. J.

AU - Heffron, T. G.

AU - Markin, Rodney Smith

AU - Pillen, T. J.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Based on our 7 and one-half-year experience with liver transplantation at the University of Nebraska Medical Center: 1. Success and growth of the program has been, in part, the result of close interaction and support of the various specialists involved. 2. We have demonstrated that outstanding patient and graft survival rates can be obtained with cyclosporine/prednisone immunosuppression. 3. Few, if any, technical contraindications exist to liver transplantation. 4. Surgical advances have allowed allografts to be salvaged which would otherwise require replacement. 5. Routine donor-liver biopsy prior to implantation has reduced the rate of primary nonfunction. 6. New strategies to improve survival for patients with hepatitis-B-related liver disease and hepatic malignancies undergoing liver transplantation need to be developed. 7. The management of patients with fulminant hepatic failure is evolving and now includes innovative approaches such as the use of ECLS and auxiliary transplants.

AB - Based on our 7 and one-half-year experience with liver transplantation at the University of Nebraska Medical Center: 1. Success and growth of the program has been, in part, the result of close interaction and support of the various specialists involved. 2. We have demonstrated that outstanding patient and graft survival rates can be obtained with cyclosporine/prednisone immunosuppression. 3. Few, if any, technical contraindications exist to liver transplantation. 4. Surgical advances have allowed allografts to be salvaged which would otherwise require replacement. 5. Routine donor-liver biopsy prior to implantation has reduced the rate of primary nonfunction. 6. New strategies to improve survival for patients with hepatitis-B-related liver disease and hepatic malignancies undergoing liver transplantation need to be developed. 7. The management of patients with fulminant hepatic failure is evolving and now includes innovative approaches such as the use of ECLS and auxiliary transplants.

UR - http://www.scopus.com/inward/record.url?scp=17644434113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17644434113&partnerID=8YFLogxK

M3 - Article

SP - 167

EP - 177

JO - Clinical transplants

JF - Clinical transplants

SN - 0890-9016

ER -